Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high efficiency and scalability for pharmaceutical intermediates.
Patent CN113072470A reveals a mild Cu-catalyzed synthesis for N-acetonitrile bis-benzenesulfonylimine derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116640146A reveals a novel Pd-catalyzed one-pot synthesis for trifluoromethyl chromonoquinolines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel carbonylation method for 2,3-dihydroquinolones offering high yields and scalable routes for pharmaceutical intermediates.
Patent CN110467579B reveals a novel iodine-promoted synthesis route offering significant cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN102985416A details a chromatography-free process for thrombin inhibitor intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for API manufacturing.
Patent CN118126005B details a metal-free synthesis route for fluorinated heterocycles offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel metal-free method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex heterocyclic compounds via scalable air atmosphere reaction.
Patent CN115215810B reveals metal-free triazole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Novel cinchona alkaloid catalyzed method for chiral chromene derivatives. High enantioselectivity up to 99% ee. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles. This method offers scalable, cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN111675662B details a novel iron-catalyzed route for quinazolinones, offering significant cost reduction and scalability for API manufacturing supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN115340460B enables high-yield indole intermediate production with reduced time and enhanced supply chain reliability for global buyers.
Patent CN111423381B reveals a mild palladium-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Patent CN105646382A reveals iodine-catalyzed synthesis offering cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN113880781B reveals glucose-based synthesis for triazoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.